SynthesisFrontiers in medicine2026
Efficacy and safety of supraglottic jet oxygenation and ventilation in Chinese patients undergoing bronchoscopic procedures: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hypoxemia remains a major complication during bronchoscopic procedures. This systematic review and meta-analysis is to systematically evaluate the efficacy and safety of supraglottic jet oxygenation and ventilation (SJOV) in preventing hypoxemia and improving clinical outcomes during bronchoscopy procedures. Methods: Databases including Embase, MEDLINE, PubMed, Cochrane Library, Weipu, SinoMed, Wanfang Data and China National Knowledge Infrastructure were searched for randomized studies comparing SJOV with other conventional oxygen therapy in adult patients undergoing diagnostic or therapeutic bronchoscopy. The primary outcome was the incidence of hypoxic events. Secondary outcomes included the need for airway assistance, arteria blood gas, peri-operative adverse events. Results: A total of 1,090 records were screened, and 10 RCTs involving 1,109 patients (555 in the SJOV group, 554 in the control group) were included, all conducted in China. SJOV significantly reduced the incidence of hypoxemia (OR = 0.20, 95%CI [0.07-0.58], Conclusion: SJOV significantly improves oxygenation, reduces hypoxemia and rescue interventions during bronchoscopy, with a manageable safety profile. It may be a valuable oxygenation strategy for bronchoscopic procedures, especially in high-risk patients. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251083408.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.